A Multimodal Quality Improvement Intervention Using the JNC Guidelines to Promote Control of Patients' BP in Federally Qualified Health Centers
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Rochester
- Enrollment
- 76
- Primary Endpoint
- Number of office visits
Study Overview
Brief Summary
Aim 1: The purpose of the study is to implement the Seventh Joint National Committee on the Diagnosis, Prevention and Treatment of Hypertension (JNC VII) recommendation for monthly visits for hypertensive patients with uncontrolled blood pressure (BP) using a theoretically-informed, empirically grounded, multimodal quality improvement (QI) intervention.
Aim 2: To improve BP control and reduce disparity in BP through implementation of monthly visits.
Aim 3: To assess potential mediators and moderators of the intervention.
Detailed Description
This study is a stepped wedged cluster randomized trial designed to improve management of uncontrolled blood pressure among patients in federally qualified health centers through the auspices of the the Clinical Directors Network Practice-Based Research Network (CDN PBRN).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Federally Qualified Health Center in the Clinic Directors Network, Practice Champion, Electronic Medical Record System
Exclusion Criteria
- •Clinicians who have been at the practice less than 6 months, Practices planning to change Electronic Medical Record systems within the next 6 months
Outcomes
Primary Outcomes
Number of office visits
Time Frame: Baseline and aniticipated at 1 year
Increase patient visit intensification for patients with uncontrolled blood pressure (BP) until the BP is under control.
Secondary Outcomes
- Reduction in Blood Pressure(Baseline and anticipated at year)
Investigators
Kevin Fiscella
MD, MPH
University of Rochester